StockData
Sanofi logo

Sanofi

SNYNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SNYNF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 17, 2026Score 6/30
$47.12−0.41 (-0.86%)

Close on Nov 18, 2026Market cap $114.92BP/E 13.4Yield –

Sanofi IFRS Basic Earnings per Share by Quarter

IFRS Basic Earnings per Share (€)

Sanofi IFRS Basic Earnings per Share: €2.52 in Q3 2026, up 9.6% from a year earlier.

Latest, Q3 2026
2.52
Period ended Sep 30, 2026
Change on a year earlier
+9.6%
2.30 in Q3 2025
History
12 quarters
Since Q4 2023
Sources
8
Documents cited below

Where the Q3 2026 figure comes from

Source: Sanofi Q3 2026 Earnings Release Form 6-K (filed 2026-10-30) ↗

Reported in Sanofi Form 6-K Appendix 3 & Form 20-F.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up IFRS Basic Earnings per Share

Cite this data

StockData. (2026). Sanofi IFRS Basic Earnings per Share (€), quarterly Q4 2023–Q3 2026 [Data set]. Compiled from Sanofi SEC filings and investor materials. https://stockdatahq.com/stocks/sny/kpis/ifrs-eps-basic

See every metric in the Sanofi KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?